Health
PDC*line Pharma presents primary clinical results from phase I/II trial on PDC*lung01 cancer vaccine at ESMO-IO 2024
(MENAFN Editorial) PDC*lung01, in combination with pembrolizumab, demonstrates the potential to provide meaningful clinical benefit compared to pembrolizumab alone in stage IV Non-Small Cell Lung ...
By: menafn
- Dec 15 2024
- 0
- 0 Views
Share this page
Guest Posts by Easy Branches
